![Jonathan Freeman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jonathan Freeman
Directeur/Membre du Conseil chez
PHIO PHARMACEUTICALS CORP.
Fortune : 35 594 $ au 31/08/2026
Profil
Dr. Jonathan E.
Freeman is a Chief Executive Officer at Artbio, Inc. and an Independent Director at Phio Pharmaceuticals Corp.
He is on the Board of Directors at Phio Pharmaceuticals Corp.
Dr. Freeman was previously employed as a Chief Operating Officer by Anthos Therapeutics, Inc., a Senior Advisor by Blackstone Life Sciences Advisors LLC, a Chief Business Officer by Vedanta Biosciences, Inc., a Senior Vice President & Head-Strategy Development by Merck KGaA, a Director-Mergers & Acquisitions by Baxter Healthcare Corp., a Head-Licensing by Serono, Inc., and a Director & Vice President by Swiss-PLG.
He received his undergraduate degree from the University of Cambridge, a graduate degree from the University of Cambridge and an MBA from Webster University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/08/2026 | 32 655 ( 0,28 % ) | 35 594 $ | 31/08/2026 |
Postes actifs de Jonathan Freeman
| Sociétés | Poste | Début |
|---|---|---|
| PHIO PHARMACEUTICALS CORP. | Directeur/Membre du Conseil | 07/06/2017 |
Artbio, Inc.
 Artbio, Inc. Hospital/Nursing ManagementHealth Services Provides redefining cancer care services | Directeur Général | 01/07/2026 |
Anciens postes connus de Jonathan Freeman
| Sociétés | Poste | Fin |
|---|---|---|
Anthos Therapeutics, Inc.
 Anthos Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutic options for the treatment of cardiovascular metabolic diseases | Fondateur | 01/09/2025 |
Vedanta Biosciences, Inc.
 Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Corporate Officer/Principal | 01/06/2018 |
| MERCK KGAA | Corporate Officer/Principal | 01/01/2016 |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Corporate Officer/Principal | 01/01/2008 |
EMD Serono, Inc.
 EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Corporate Officer/Principal | 01/01/2005 |
Formation de Jonathan Freeman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
69
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Health Technology |
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Webster University
 Webster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Health Technology |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Health Technology |
Phio Pharmaceuticals Corp.
 Phio Pharmaceuticals Corp. BiotechnologyHealth Technology Develops RNAi-based medical technologies and therapies | Health Technology |
Swiss-PLG | |
Blackstone Life Sciences Advisors LLC
 Blackstone Life Sciences Advisors LLC Investment ManagersFinance Blackstone Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields on pharmaceutical, biotechnology and medical technology sectors. It provides financing for growth stage transactions. | Finance |
Anthos Therapeutics, Inc.
Anthos Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutic options for the treatment of cardiovascular metabolic diseases | Health Technology |
Artbio, Inc.
Artbio, Inc. Hospital/Nursing ManagementHealth Services Provides redefining cancer care services | Health Services |
